People who quit taking popular GLP-1 drugs such as Ozempic might their jeopardize heart health, according to a new study.
In India, China and several other nations, Novo Nordisk is on the verge of losing patent protection for its blockbuster ...
New research challenges fears about Ozempic weight regain. Cleveland Clinic study of 8,000 patients finds minimal rebound after stopping GLP-1 medications.
A St. Johns County man has been charged with illegally selling weight-loss drug ingredients. Adam K. Taylor is accused of ...
Research out today might provide even more of a reason for people to stay on GLP-1 medications like semaglutide, the active ...
Swedish people with depression and anxiety who took Novo Nordisk A/S’s blockbuster shots Ozempic and Wegovy were less likely ...
Ozempic has been a breakthrough for many, correcting eating disorders and managing blood sugar, weight, and more. A recent New Yorker article highlights an under-discussed bio-psychological side ...
Brianna believes Ozempic has a devastating side effect. The post Brianna Chickenfry Has Deadly Warning for Ozempic Users ...
“The bottom line I would convey to patients is that tried and true lifestyle interventions — adequate protein, fiber, ...
Kidney Disease,” an editorially independent special report that was produced with financial support from Vertex. M ore than one in sev ...
Comedian Gabriel Iglesias could have earned $1 million, but his Ozempic revelation explains why he walked away.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results